Organon & Co (OGN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $3.65B
Last updated: Nov 17, 2026 at 4:20 PM ET
Organon & Co (OGN) Stock Chart
Organon (OGN) has a latest price of $13.90 on Nov 17, 2026, 0.1% below its 52-week high of $13.91. Its price rose 85.9% over the past 12 months. The month-end price fell 62.3% over the 5 years through Oct 2026, a compound annual decline of 17.7%.
Price Chart
From Jun 2021 to Oct 2026, its highest month-end close was $37.96 in May 2022 and its lowest $5.99 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 1.4%, and over 6 months it rose 3.7%. The month-end price fell 6.4% over the 3 years through Oct 2026, a compound annual decline of 2.2%.
| Period | Change |
|---|---|
| 1 month | +1.2% |
| 3 months | +1.4% |
| 6 months | +3.7% |
| 12 months | +85.9% |
| 12 months, with dividends | +87.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -6.4% | -2.2% |
| 5 years | -62.3% | -17.7% |
Price by Year
Its best calendar year was 2024, when the price rose 3.5%, and its weakest was 2025, when it fell 51.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $13.84 | +93.0% |
| 2025 | $7.17 | -51.9% |
| 2024 | $14.92 | +3.5% |
| 2023 | $14.42 | -48.4% |
| 2022 | $27.93 | -8.3% |
Trading Range
The price is 1.1% above its 50-day average of $13.75 and 18.0% above its 200-day average of $11.78.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $13.90 | |
| 52-week high | $13.91 | -0.1% |
| 52-week low | $5.67 | +145.1% |
| 50-day average | $13.75 | +1.1% |
| 200-day average | $11.78 | +18.0% |
Price Risk
Over 3 years, its largest fall from a peak was 74.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.57 |
| Largest fall, 1 year | -41.5% |
| Largest fall, 3 years | -74.1% |
Valuation
Organon traded at 2.0x earnings at the end of 2025, against a 5-year median of 4.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OGN
What is OGN's 1-year price change?
Organon's price rose 85.9% over the past 12 months. With dividends included, the 12-month total return was 87.2%.
What is OGN's 5-year price change?
Organon's month-end price fell 62.3% over the 5 years through Oct 2026, a compound annual decline of 17.7%. These figures leave out dividends.
What is OGN's 52-week high and low?
Organon's 52-week high is $13.91 and its 52-week low is $5.67. Its latest price of $13.90 on Nov 17, 2026 is 0.1% below the high.
What is OGN's beta?
Organon's 1-year beta against the S&P 500 is 0.57, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 41.5%.
Is the OGN chart free?
Yes. Advanced Charting for OGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OGN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors